The nondepolarizing, normokalemic cardioplegia formulation adenosine-lidocaine (adenocaine) exerts anti-neutrophil effects by synergistic actions of its components

Journal of Thoracic and Cardiovascular Surgery

Volumn 143, Issue 5, 2012, Pages 1167-1175

  Shi, Weiwei ^a   Jiang, Rong ^a   Dobson, Geoffrey P ^b   Granfeldt, Asger ^c   Vinten Johansen, Jakob ^a  

^a EMORY UNIVERSITY   (United States)

^b JAMES COOK UNIVERSITY   (Australia)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCAINE; ADENOSINE; ANTIINFLAMMATORY AGENT; CALCEIN; CD11B ANTIGEN; CD18 ANTIGEN; CYTOCHALASIN B; FORMYLMETHIONYLLEUCYLPHENYLALANINE; GLYCOPROTEIN P 15095; LIDOCAINE; OXYGEN; SUPEROXIDE; THROMBOCYTE ACTIVATING FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIINFLAMMATORY ACTIVITY; ARTERY ENDOTHELIUM; ARTICLE; CARDIOPLEGIA; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY; ENDOTHELIUM CELL; FLOW CYTOMETRY; LEUKOCYTE ACTIVATION; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION INHIBITION; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL;

ADENOSINE; ANESTHETICS, LOCAL; ANIMALS; ANTIGENS, CD11; ANTIGENS, CD18; CARDIOPLEGIC SOLUTIONS; CELL ADHESION; CELLS, CULTURED; COCULTURE TECHNIQUES; CORONARY VESSELS; CYTOCHALASIN B; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; DRUG SYNERGISM; FLOW CYTOMETRY; LIDOCAINE; LUMINESCENT MEASUREMENTS; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHIL ACTIVATION; NEUTROPHILS; PLATELET ACTIVATING FACTOR; SUPEROXIDES; SWINE; TIME FACTORS; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION;

EID: 84859769097     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2011.06.045     Document Type: Article

References (32)

1. Damiano RJ Jr. The electrophysiology of ischemia and cardioplegia: implications for myocardial protection. J Card Surg. 1995;10(4 Suppl):445-53.
2. + currents in rat ventricular myocytes. Prog Biophys Mol Biol. 2006;90:249-69.
3. Chambers DJ. Polarization and myocardial protection. Curr Opin Cardiol. 1999;14:495-500.
4. Dobson GP, Jones MW. Adenosine and lidocaine: a new concept in nondepolarizing surgical myocardial arrest, protection, and preservation. J Thorac Cardiovasc Surg. 2004;127:794-805. (Pubitemid 38316186)
5. Dobson GP. Membrane polarity: a target for myocardial protection and reduced inflammation in adult and pediatric cardiothoracic surgery. J Thorac Cardiovasc Surg. 2010;140:1213-7.
6. Sloots KL, Dobson GP. Normokalemic adenosine-lidocaine cardioplegia: importance of maintaining a polarized myocardium for optimal arrest and reanimation. J Thorac Cardiovasc Surg. 2010;139:1576-86.
7. Corvera JS, Kin H, Dobson GP, Kerendi F, Halkos ME, Katzmark S, et al. Polarized arrest with warm or cold adenosine/lidocaine blood cardioplegia is equivalent to hypothermic potassium blood cardioplegia. J Thorac Cardiovasc Surg. 2005;129:599-606. (Pubitemid 40311320)
8. O'Rullian JJ, Clayson SE, Peragallo R. Excellent outcomes in a case of complex re-do surgery requiring prolonged cardioplegia using a new cardioprotective approach: Adenocaine. J Extra Corpor Technol. 2008;40:203-5.
9. Vinten-Johansen J. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc Res. 2004;61:481-97. (Pubitemid 38210154)
10. Cronstein BN. Adenosine, an endogenous anti-inflammatory agent. J Appl Physiol. 1994;76:5-13. (Pubitemid 24048220)
11. Cassuto J, Sinclair R, Bonderovic M. Anti-inflammatory properties of local anesthetics and their present and potential clinical implications. Acta Anaesthesiol Scand. 2006;50:265-82.
12. 3 adenosine receptor activation attenuates neutrophil function and neutrophil-mediated reperfusion injury. Am J Physiol. 1999;277(5 Pt 2):H1895-905.
13. 2 receptor activation attenuates reperfusion injury by inhibiting neutrophil accumulation, superoxide generation and coronary endothelial adherence. J Pharmacol Exp Ther. 1997;280:301-9.
14. Eskitascioglu T, Karaci S, Canoz O, Kilic E, Gunay GK. The impact of lidocaine on flap survival following reperfusion injury. J Surg Res. 2011;167:323-8.
15. Zhao ZQ, Sato H, Williams MW, Fernandez AZ, Vinten-Johansen J. Adenosine A2-receptor activation inhibits neutrophil-mediated injury to coronary endothelium. Am J Physiol. 1996;271(4 Pt 2):H1456-64.
16. Condliffe AM, Kitchen E, Chilvers ER. Neutrophil priming: pathophysiological consequences and underlying mechanisms. Clin Sci (Lond). 1998;94:461-71. (Pubitemid 28205909)
17. Granfeldt A, Shi W, Schmarkey LS, Jiang R, Bone CC, Wogensen L, et al. The combination of adenosine and lidocaine (Adenocaine) improves postresuscitation cardiac function following cardiac arrest. Circulation. 2010;122(Meeting Abstracts):A68.
18. Zhou W, Arrabit C, Choe S, Slesinger PA. Mechanism underlying bupivacaine inhibition of G protein-gated inwardly rectifying K+ channels. Proc Natl Acad Sci U S A. 2001;98:6482-7. (Pubitemid 32488263)
19. Kindler CH, Yost CS. Two-pore domain potassium channels: new sites of local anesthetic action and toxicity. Reg Anesth Pain Med. 2005;30:260-74. (Pubitemid 40718909)
20. Arakawa K, Takahashi H, Nakagawa S, Ogawa S. The effects of lidocaine on superoxide production and p47 Phox translocation in opsonized zymosan-activated neutrophils. Anesth Analg. 2001;93:1501-6. (Pubitemid 33111677)
21. Lahav M, Levite M, Bassani L, Lang A, Fidder H, Tal R, et al. Lidocaine inhibits secretion of IL-8 and IL-1beta and stimulates secretion of IL-1 receptor antagonist by epithelial cells. Clin Exp Immunol. 2002;127:226-33. (Pubitemid 34233927)
22. MacGregor RR, Thorner RE, Wright DM. Lidocaine inhibits granulocyte adherence and prevents granulocyte delivery to inflammatory sites. Blood. 1980;56:203-9. (Pubitemid 10043418)
23. Fischer LG, Bremer M, Coleman EJ, Conrad B, Krumm B, Gross A, et al. Local anesthetics attenuate lysophosphatidic acid-induced priming in human neutrophils. Anesth Analg. 2001;92:1041-7. (Pubitemid 32239155)
24. Jinnouchi A, Aida Y, Nozoe K, Maeda K, Pabst MJ. Local anesthetics inhibit priming of neutrophils by lipopolysaccharide for enhanced release of superoxide: suppression of cytochrome b558 expression by disparate mechanisms. J Leukoc Biol. 2005;78:1356-65. (Pubitemid 41779242)
25. Bylund J, Pellme S, Fu H, Mellqvist U-H, Hellstrand K, Karlsson A, et al. Cytochalasin B triggers a novel pertussis toxin sensitive pathway in TNF-alpha primed neutrophils. BMC Cell Biology. 2004;5:21.
26. Stewart AG, Harris T. Adenosine inhibits platelet-activating factor, but not tumor necrosis factor-alpha-induced priming of human neutrophils. Immunology. 1993;78:152-8. (Pubitemid 23035863)
27. Hollmann MW, Gross A, Jelacin N, Durieux ME. Local anesthetic effects on priming and activation of human neutrophils. Anesthesiology. 2001;95:113-22. (Pubitemid 32623004)
28. Rao RM, Yang L, Garcia-Cardena G, Luscinskas FW. Endothelial-dependent mechanisms of leukocyte recruitment to the vascular wall. Circ Res. 2007;101:234-47. (Pubitemid 47344073)
29. Cronstein BN, Levin RI, Belanoff J, Weissmann G, Hirschhorn R. Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells. J Clin Invest. 1986;78:760-70. (Pubitemid 16024813)
30. Schiffer CA, Sanel FT, Young VB, Aisner J. Reversal of granulocyte adherence to nylon fibers using local anesthetic agents: possible application to filtration leukapheresis. Blood. 1977;50:213-25. (Pubitemid 8140394)
31. Grisham MB, Hernandez LA, Granger DN. Adenosine inhibits ischemia-reperfusion-induced leukocyte adherence and extravasation. Am J Physiol. 1989;257(5 Pt 2):H1334-9.
32. McCafferty DM, Sharkey KA, Wallace JL. Beneficial effects of local or systemic lidocaine in experimental colitis. Am J Physiol. 1994;266(4 Pt 1):G560-7. (Pubitemid 24150912)